Elevance Health Inc. Common Stock (ELV)
Stock · NYSE · Health Care
$428.26as of 10/16/2026
Price chart
Active signals
ELV Signal Track Record
How signals performed across all stocks →What ELV's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 36 | -0.8% | 44% | September 15, 2026 |
| Bollinger Band Breakdown | 24 | +0.3% | 50% | October 1, 2026 |
| Bollinger Band Breakout | 25 | -1.3% | 36% | September 3, 2026 |
| 200-Day Moving Average TouchActive now | 21 | -1.0% | 43% | April 17, 2026 |
| Any 20-session window (baseline) | +0.1% | 51% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based a…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 96,129
- Website
- www.elevancehealth.com/
Fundamentals
- 1-day range
- $420.99$433.89
- Market cap
- $84.88B
- P/E (trailing)
- 18.75
- P/E (forward)
- 14.37
- EPS (trailing)
- $22.50
- Dividend yield
- 1.24%
- Beta
- 0.65
- Avg. volume
- 1.20M
- Ex-dividend date
- September 10, 2026
- Dividend pay date
- September 25, 2026
How Elevance Health Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 6, 2026 · via SEC EDGAR / Finnhub
Forecasts
21 analyst ratings
Elevance Health Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ELVElevance Health Inc. Common Stock$428.26▼ 0.04%Market cap $84.88BP/E 18.75$274.84$436.24
- CIThe Cigna Group Common Stock$302.3▲ 1.17%Market cap $72.73BP/E 12.15$239.51$311.34
- HUMHumana Inc. Common Stock$413.16▼ 4.41%Market cap $44.10BP/E 39.25$163.11$456.5
- NTRANatera Inc. Common Stock$393.44▼ 2.80%Market cap $38.01BP/E —$170.82$437.41
- CNCCentene Corporation Common Stock$69.16▼ 1.91%Market cap $31.71BP/E —$31.63$70.37
- ILMNIllumina Inc. Common Stock$262.54▼ 2.01%Market cap $29.25BP/E 48.62$88$309.35
- DGXQuest Diagnostics Incorporated Common Stock$235▼ 1.74%Market cap $26.32BP/E 24.67$171.18$248.84
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ELV Elevance Health Inc. Common Stock | $84.88B | 18.75 | $428.26 | ▼ 0.04% | $274.84$436.24 |
| CI The Cigna Group Common Stock | $72.73B | 12.15 | $302.3 | ▲ 1.17% | $239.51$311.34 |
| HUM Humana Inc. Common Stock | $44.10B | 39.25 | $413.16 | ▼ 4.41% | $163.11$456.5 |
| NTRA Natera Inc. Common Stock | $38.01B | — | $393.44 | ▼ 2.80% | $170.82$437.41 |
| CNC Centene Corporation Common Stock | $31.71B | — | $69.16 | ▼ 1.91% | $31.63$70.37 |
| ILMN Illumina Inc. Common Stock | $29.25B | 48.62 | $262.54 | ▼ 2.01% | $88$309.35 |
| DGX Quest Diagnostics Incorporated Common Stock | $26.32B | 24.67 | $235 | ▼ 1.74% | $171.18$248.84 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Is Elevance Health (ELV) Undervalued After Its Recent Share Price Rally?Yahoo · 10/10/2026
- Has Elevance Health (ELV) Earned Its Discount After Medicare Updates?Yahoo · 10/10/2026
- Humana Leads Managed Care Peers in 2027 Medicare Advantage Star Ratings, Deutsche Bank SaysYahoo · 10/9/2026
- Clover Health Investments shares are trading higher after the company reported a year-over-year increase in Membership Growth in its Medicare Advantage PPO plans. The company expects to achieve its first-ever FY GAAP net income profitability.Benzinga · 10/9/2026
- Is Clover Health Stock Too Dependent On One Group Of Members?Yahoo · 10/9/2026
- Humana Reaffirms FY26 Adjusted EPS Guidance Of At Least $9; Exceeding Goal Of Top Quartile Results In 2027 Medicare Advantage Star Ratings; Expects 2028 Benefit For One-Time Investments And Return To ShareholdersBenzinga · 10/9/2026
- CVS Health Trades at a Discount to Industry: How to Play the Stock?Yahoo · 10/8/2026
- 2026 U.S. Midterm Elections: What To Buy, What To AvoidSeekingAlpha · 10/8/2026
Insider Activity
Insider Actions →- Mark Kaye · October 2, 2026 · Grant2.6K
- Mark Kaye · October 2, 2026 · Tax Withholding4.2K @ $386.43
- Erin M. Wessling · September 3, 2026 · Tax Withholding255 @ $414.78
- Erin M. Wessling · September 2, 2026 · Tax Withholding94 @ $405.84
- Ryan R. Craig · September 2, 2026 · Tax Withholding144 @ $405.84
- Gail Boudreaux · July 17, 2026 · Buy2.0K @ $368.25
- Gail Boudreaux · July 17, 2026 · Buy680 @ $366.41
- Ramiro G. Peru · July 17, 2026 · Buy1.0K @ $366.05
- Ronald W. Penczek · June 12, 2026 · Sale369 @ $403.16
- Robert L. Dixon Jr. · June 11, 2026 · Sale151 @ $401.77
- Ronald W. Penczek · May 19, 2026 · Option Exercise877 @ $311.48
- Ronald W. Penczek · May 19, 2026 · Option Exercise654 @ $271.27
- Ronald W. Penczek · May 19, 2026 · Sale1.5K @ $403.13
- Ryan M. Schneider · May 13, 2026 · Grant563
- Bahija Jallal · May 13, 2026 · Grant563
Institutional Ownership
March 31, 2026
- Total shares held
- 187.15M
- Total value held
- $51.71B
- Institutional holders
- 1452
- Unknown19.89M
- Unknown14.35M
- Unknown10.29M
- Unknown8.23M
- Unknown5.89M
- Unknown5.19M
- Unknown5.14M
- Unknown5.13M
- Unknown4.82M
- Unknown4.75M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Elevance Health Q3 Outlook: Premium Pressures and Sector Peer Trends
Elevance Health is preparing for its third-quarter earnings report, with analysts examining key metrics and the potential impact of lower premiums on the company's results. Broader sector news highlights peers like UnitedHealth, Centene, and Oscar Health pursuing growth and cost-saving strategies amidst shifting premium dynamics. The market is observing how these competitive and industry-wide pressures will align with Elevance Health's upcoming performance.
Elevance Health Q3 Outlook: Premium Pressures and Sector Peer Trends. Elevance Health is preparing for its third-quarter earnings report, with analysts examining key metrics and the potential impact of lower premiums on the company's results. Broader sector news highlights peers like UnitedHealth, Centene, and Oscar Health pursuing growth and cost-saving strategies amidst shifting premium dynamics. The market is observing how these competitive and industry-wide pressures will align with Elevance Health's upcoming performance.